Novel TKI-resistant BCR-ABL1 gatekeeper residue mutations retain in vitro sensitivity to axitinib
Crossref DOI link: https://doi.org/10.1038/leu.2015.303
Published Online: 2015-10-29
Published Print: 2016-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lasater, E A
Massi, E S
Stecula, A
Politi, J
Tan, S K
Smith, C C
Gunthorpe, M
Holmes, J P
Chehab, F
Sali, A
Shah, N P
Text and Data Mining valid from 2015-10-29
Version of Record valid from 2015-10-29
Article History
First Online: 29 October 2015
Competing interests
: The authors declare no conflict of interest.